Amneal Pharmaceuticals, Inc.
← Back to AMRX Overview

Amneal Pharmaceuticals, Inc. (AMRX)

Revenue & Top-Line Growth

Latest Revenue

$796.2M

Financial Fundamentals

AMRXQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-06-300.80B+10.2%+9.9%3.12B+9.3%
2026-03-310.72B-11.3%+3.9%3.05B+7.6%
2025-12-310.81B+3.8%+11.5%3.02B+8.0%
2025-09-300.78B+8.3%+11.7%2.93B+9.5%
2025-06-300.72B+4.2%+3.2%2.85B+9.8%
2025-03-310.70B-4.8%+5.5%2.83B+13.4%
2024-12-310.73B+4.0%+18.4%2.79B+16.7%
2024-09-300.70B+0.1%+13.3%2.68B+12.3%
2024-06-300.70B+6.5%+17.1%2.60B+12.4%
2024-03-310.66B+6.8%+18.2%2.50B+9.8%
2023-12-310.62B-0.5%+1.2%2.39B+8.2%
2023-09-300.62B+3.5%+13.7%2.39B+11.5%
2023-06-300.60B+7.4%+7.1%2.31B+8.9%
2023-03-310.56B-8.6%+12.0%2.27B+8.3%
2022-12-310.61B+11.8%+13.6%2.21B+5.7%
2022-09-300.55B-2.5%+3.2%2.14B+3.5%
2022-06-300.56B+12.4%+4.5%2.12B+3.2%
2022-03-310.50B-7.3%+0.9%2.10B+5.6%
2021-12-310.54B+1.6%+5.3%2.09B+5.1%
2021-09-300.53B-1.2%+1.8%2.07B+9.9%
2021-06-300.54B+8.5%+15.2%2.06B+18.3%
2021-03-310.49B-3.3%-1.1%1.99B+18.4%
2020-12-310.51B-1.8%+28.4%1.99B+22.5%
2020-09-300.52B+11.8%+37.3%1.88B+8.9%
2020-06-300.46B-6.8%+14.8%1.74B-4.7%
2020-03-310.50B+25.5%+11.7%1.68B-8.5%
2019-12-310.40B+5.0%-20.1%1.63B-2.2%
2019-09-300.38B-6.5%-20.6%1.73B+18.4%
2019-06-300.40B-9.3%-2.2%1.82B+47.5%
2019-03-310.45B-10.3%+62.1%1.83B+69.3%
2018-12-310.50B+4.4%+69.6%1.66B+60.9%
2018-09-300.48B+15.2%+87.1%1.46B+40.4%
2018-06-300.41B+50.4%+59.2%1.24B
2018-03-310.28B-6.2%+21.9%1.08B
2017-12-310.29B+15.2%-1.7%1.03B
2017-09-300.25B-2.0%1.04B
2017-06-300.26B+15.1%0.00B
2017-03-310.23B-24.4%0.00B
2016-12-310.30B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20253.02B+8.0%
20242.79B+16.7%
20232.39B+8.2%
20222.21B+5.7%
20212.09B+5.1%
20201.99B+22.5%
20191.63B-2.2%
20181.66B+60.9%
20171.03B+1.5%
20161.02B+17.5%
20150.87B+10.3%
20140.79B